Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Preferred Stock Liabilities (2019 - 2022)

Korro Bio (KRRO) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $57.7 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Preferred Stock Liabilities changed 0.0% year-over-year to $57.7 million, compared with a TTM value of $57.7 million through Dec 2022, changed 0.0%, and an annual FY2022 reading of $57.7 million, changed 0.0% over the prior year.
  • Preferred Stock Liabilities was $57.7 million for Q4 2022 at Korro Bio, roughly flat from $57.7 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $57.7 million in Q4 2021 and bottomed at $57.7 million in Q4 2021.